Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other neoplasm 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Dermatologic 1

Conditions

Multiple Myeloma 131Hodgkin Disease 90Leukemia, Lymphocytic, Chronic, B-Cell 88Precursor Cell Lymphoblastic Leukemia-Lymphoma 79Myelodysplastic Syndromes 77Lymphoma, Non-Hodgkin 74Leukemia, Myeloid, Acute 72Lymphoma, Mantle-Cell 67Lymphoma, Follicular 67Lymphoma 63Leukemia 63Lymphoma, Large B-Cell, Diffuse 62Lymphoma, B-Cell, Marginal Zone 61Burkitt Lymphoma 57Neoplasms, Plasma Cell 56Myeloproliferative Disorders 55Lymphoma, Large-Cell, Immunoblastic 51Congenital Abnormalities 50Leukemia, Myeloid, Chronic-Phase 48Leukemia, Myelomonocytic, Chronic 43Leukemia, Myeloid, Accelerated Phase 41Primary Myelofibrosis 40Waldenstrom Macroglobulinemia 38Dendritic Cell Sarcoma, Interdigitating 34Recurrence 33Lymphoma, T-Cell, Cutaneous 32Leukemia, Myelogenous, Chronic, BCR-ABL Positive 32Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 31Lymphoma, Large-Cell, Anaplastic 31Sezary Syndrome 30

Interventions

Trimethoprim, Sulfamethoxazole Drug Combination 7Ciprofloxacin 5gamma-Globulins 3Amoxicillin-Potassium Clavulanate Combination 3liposomal amphotericin B 2Trimethoprim 2Sulfamethoxazole 2Peripheral Blood Stem Cell Transplantation 2Pentetic Acid 2Moxifloxacin 2Melphalan 2Itraconazole 2Immunoglobulins, Intravenous 2Cyclophosphamide 2Caspofungin 2talquetamab 1idecabtagene vicleucel 1fludarabine phosphate 1ethanolamine oleate 1amphotericin B, deoxycholate drug combination 1Whole-Body Irradiation 1Watchful Waiting 1Voriconazole 1Vancomycin 1Valacyclovir 1Therapeutics 1Tazobactam 1Tacrolimus 1Sodium Chloride 1Sirolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Infections × fludarabine phosphate × Plasma cell × Clear all
NCT00589563 2014-09-10

Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

City of Hope Medical Center

Phase 2 Completed
32 enrolled 24 charts
DermatologicLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cell

Congenital Abnormalities, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Immunoblastic Lymphadenopathy, Infections, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Precancerous Conditions, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡